Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5results about How to "Improve functional status" patented technology

Anti-receding distraction interbody fusion cage

InactiveCN119015021Arestore natural heightimprove functional statusJoint implantsSpinal implantsHuman bodySpinal column
The invention discloses an anti-retreat distractable interbody fusion cage which comprises a fusion cage body, a distracting inner core and a pushing piece, a distracting channel is formed in the front portion of the fusion cage body, a first distracting body and a second distracting body which can expand outwards are arranged on the two sides of the distracting channel respectively, and anti-retreat structures are arranged on the first distracting body and the second distracting body respectively; the distraction inner core is arranged in the distraction channel in a sliding mode, and the propelling piece is movably arranged on the fusion cage body and used for driving the distraction inner core to slide in the distraction channel towards the front portion of the fusion cage body so that the first distraction body and the second distraction body can both expand outwards. The fusion cage can be expanded after being implanted into the intervertebral space of the human body, so that a surgeon can accurately complete implantation in a limited space more easily, the stability and durability of the fusion cage in the body are improved, the design is directly beneficial to remodeling and maintaining the physiological lordosis of the lumbar vertebra, and the fusion cage is suitable for popularization and application. The method is crucial for reducing postoperative waist and back pain, improving spine functions and preventing long-term complications.
Owner:BEIJING CHUNLIZHENGDA MEDICAL INSTR

An aged adipose tissue-derived mesenchymal stem cell pretreated by MK8722, a preparation method and application thereof

ActiveCN122405544Bimprove functional statusreduced motor function
The present application relates to the field of cell therapy and regenerative medicine, and in particular to a kind of old age adipose tissue-derived mesenchymal stem cells pretreated by MK8722, its preparation method and application.The method comprises the following steps: the old age adipose tissue-derived mesenchymal stem cells are inoculated in culture solution containing MK8722 to carry out in vitro treatment, and first cells are obtained;The culture solution containing MK8722 is removed, and the first cells are washed to obtain second cells;Second cells are cultured using culture solution without MK8722, and the old age adipose tissue-derived mesenchymal stem cells pretreated by MK8722 are obtained.The cells obtained by the method, relative to the old age adipose tissue-derived mesenchymal stem cells without the in vitro treatment, show at least one improvement in proliferation capacity, continuous passage amplification capacity, adipogenic differentiation capacity or chondrogenic differentiation capacity, and can be used to prepare products for treating or alleviating osteoarthritis.
Owner:HAINAN MEDICAL UNIV

A composition, pharmaceutical preparation and use for treating a vascular-bone coupling imbalance disease

PendingCN122351273Apromote new lifeReduce levels of apoptosisDiseaseVascular endothelium
The application belongs to the field of treating blood vessel-bone coupling imbalance diseases in traditional Chinese medicine, and particularly relates to a composition for treating blood vessel-bone coupling imbalance diseases, a pharmaceutical preparation and application. Geniposide alone or in combination with crocin I can effectively reduce endothelial cell damage under pathological stimulation conditions, reduce the level of cell apoptosis and the degree of oxidative stress, improve the vascular endothelial function state, and can also significantly inhibit osteoclast differentiation, reduce the number of mature osteoclasts, and reduce bone resorption activity, thereby being conducive to restoring the dynamic balance between bone formation and bone resorption.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES +1

Composition for treating brain injury and neurodegenerative disease and application thereof

The invention relates to the technical field of neurology, in particular to a composition for treating brain injury and neurodegenerative lesion and application thereof, the composition is composed of an antioxidant and an anti-inflammatory drug, the antioxidant comprises vitamins, flavonoids, polysaccharides, saponins and active peptides according to the mass ratio of 4: 3: 1: 4: 2, and the content of the antioxidant is 60-80 parts; the anti-inflammatory drug comprises a non-steroidal anti-inflammatory drug NSAIDs, and the number of the components of the anti-inflammatory drug is 20-40 parts. By utilizing the synergistic effect of various active ingredients, the traditional Chinese medicine composition can comprehensively improve the symptoms of a patient, relieve pain, improve sleep and improve the cognitive function, thereby delaying neurodegenerative diseases and being beneficial to improving the functional state of neurons.
Owner:陈琨

Formula of feed additive capable of reducing acid and protecting kidney

The invention discloses a feed additive formula capable of reducing acid and protecting kidney. The feed additive formula comprises the following components: yucca extract, silymarin, chitosan, potassium citrate, medicinal charcoal, vitamin C, vitamin and bentonite. The invention belongs to the technical field of feed additive formulas, and particularly relates to a feed additive formula for reducing acid and protecting kidney.
Owner:ZHENGZHOU WALKER BIOTECHNOLOGY CO LTD